Wird geladen...
4CPS-109 Experience of regorafenib use in metastatic colorectal cancer
BACKGROUND: Regorafenib has been approved for the treatment of patients with previously treated metastatic colorectal cancer (mCRC), and may be considered as a treatment for selected patients. PURPOSE: To evaluate the efficacy and safety of regorafenib treatment in patients with mCRC. MATERIAL AND M...
Gespeichert in:
| Veröffentlicht in: | Eur J Hosp Pharm |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535196/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.200 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|